Regulus Therapeutics 8-K Shows Co. Received Notice From Nasdaq The Co.'s Shareholders' Equity Reported On 1-Q For Qtr. Ended Sep. 30, 2018 Does Not Satisfy Continued Listing Requirement
Benzinga Newsdesk